Results 31 to 40 of about 42,710 (216)

Levosimendan for the prevention of acute organ dysfunction in sepsis [PDF]

open access: yes, 2016
BACKGROUND Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis. METHODS We conducted a double-blind, randomized clinical trial to investigate whether levosimendan reduces the ...
Al-Beidh, F   +16 more
core   +2 more sources

Evaluation of the anti-ischemic effects of D-ribose during dobutamine stress echocardiography: a pilot study

open access: yesCardiovascular Ultrasound, 2009
D-Ribose, a pentose sugar, has shown to improve myocardial high-energy phosphate stores depleted by ischemia. This study investigated the ability of D-Ribose with low dose dobutamine to improve the contractile response of viable myocardium to dobutamine ...
Gradus-Pizlo Irmina   +6 more
doaj   +1 more source

Characterizing cardiac involvement in chronic kidney disease using CMR—a systematic review [PDF]

open access: yes, 2018
Purpose of Review: The aim of the review was to identify and describe recent advances (over the last 3 years) in cardiac magnetic resonance (CMR) imaging in patients with chronic kidney disease (CKD).
Mangion, Kenneth   +3 more
core   +1 more source

Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy

open access: yesCardiovascular Ultrasound, 2003
Background It has been suggested that an extensive contractile reserve identified recognised by means of dobutamine stress echocardiography may predict a better prognosis in patients with severe left ventricular dysfunction at rest. However, the clinical
Campana Carlo   +6 more
doaj   +1 more source

Na+-induced Ca2+ influx through reverse mode of Na+-Ca2+ exchanger in mouse ventricular cardiomyocyte [PDF]

open access: yes, 2015
BACKGROUND: Dobutamine is commonly used for clinical management of heart failure and its pharmacological effects have long been investigated as inotropics via β-receptor activation.
Ban, Tao   +7 more
core   +3 more sources

Time to re-think the use of dobutamine in sepsis

open access: yesJournal of Intensive Care, 2017
Dobutamine is commonly used worldwide and included in the protocol for early goal-directed therapy (EGDT). Since the use of dobutamine in EGDT was reported, it has been considered to be an important component, especially in the treatment of septic ...
Ryota Sato, Michitaka Nasu
doaj   +1 more source

Intrinsic Frequency Analysis and Fast Algorithms [PDF]

open access: yes, 2017
Intrinsic Frequency (IF) has recently been introduced as an ample signal processing method for analyzing carotid and aortic pulse pressure tracings. The IF method has also been introduced as an effective approach for the analysis of cardiovascular system
Koorehdavoudi, Hana   +2 more
core   +3 more sources

Levosimendan in Sepsis. [PDF]

open access: yes, 2017
Commentum to "Levosimendan for the Prevention of Acute Organ Dysfunction in ...
Morelli, Andrea, Tritapepe, Luigi
core   +1 more source

Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga   +20 more
wiley   +1 more source

Dobutamine-induced strain and strain rate predict viability following fibrinolytic therapy in patients with ST-elevation myocardial infarction

open access: yesFrontiers in Cardiovascular Medicine, 2015
Background: Low-dose dobutamine stress echocardiography is increasingly used for identifying myocardial viability.Aim: We explored whether dobutamine-induced strain (S) and strain rate (SR) can identify myocardial viability following fibrinolytic therapy
Mohamed eIsmail, Wail eNammas
doaj   +1 more source

Home - About - Disclaimer - Privacy